Advertisement
Advertisement

ANIX

ANIX logo

Anixa Biosciences, Inc.

3.00
USD
Sponsored
+0.04
+1.35%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

3.03

+0.03
+1.00%

Anixa Biosciences, Inc. Profile

About

Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.

Info & Links

CEO

Amit Kumar

Headquarters

3150 ALMADEN EXPRESSWAY, SUITE 250
SAN JOSE, CA 95118, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.anixa.com

Auditor

HASKELL & WHITE LLP

Share holders

280

Employees

4

Anixa Biosciences, Inc. Statistics

Valuation Measures

Market Capitalization2

101.59M

Enterprise Value

100.04M

Enterprise Value/EBITDA(ttm)

-9.23

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

6.61

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-70.95%

Return on Invested Capital(ttm)

-71.85%

Return on Assets(ttm)

-62.53%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-10.84M

Net Income Available to Common(ttm)

-10.31M

Diluted EPS(ttm)

-0.33

Share Statistics

Beta (5Y Monthly)

0.57

52-Week Change

14.07%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

33.53M

Dividend Yield

0.00%

Float4

24.68M

% Held by Insiders

26.40%

% Held by Institutions

29.13%

Balance Sheet

Total Cash(mrq)

14.20M

Total Cash Per Share(mrq)

0.42

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

12.18%

Quick Ratio(mrq)

12.18%

Book Value Per Share(mrq)

0.41

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.08

Free Cash Flow(ytd)

-2.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement